268 related articles for article (PubMed ID: 20950612)
1. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
Arrenberg P; Maricic I; Kumar V
Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.
Maricic I; Sheng H; Marrero I; Seki E; Kisseleva T; Chaturvedi S; Molle N; Mathews SA; Gao B; Kumar V
Hepatology; 2015 Apr; 61(4):1357-69. PubMed ID: 25477000
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
[TBL] [Abstract][Full Text] [Related]
4. Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury.
Yang SH; Lee JP; Jang HR; Cha RH; Han SS; Jeon US; Kim DK; Song J; Lee DS; Kim YS
J Am Soc Nephrol; 2011 Jul; 22(7):1305-14. PubMed ID: 21617126
[TBL] [Abstract][Full Text] [Related]
5. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
[TBL] [Abstract][Full Text] [Related]
6. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.
Li L; Huang L; Sung SS; Lobo PI; Brown MG; Gregg RK; Engelhard VH; Okusa MD
J Immunol; 2007 May; 178(9):5899-911. PubMed ID: 17442974
[TBL] [Abstract][Full Text] [Related]
7. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis.
Maricic I; Halder R; Bischof F; Kumar V
J Immunol; 2014 Aug; 193(3):1035-46. PubMed ID: 24973441
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.
Sebode M; Wigger J; Filpe P; Fischer L; Weidemann S; Krech T; Weiler-Normann C; Peiseler M; Hartl J; Tolosa E; Herkel J; Schramm C; Lohse AW; Arrenberg P
Front Immunol; 2019; 10():1065. PubMed ID: 31191516
[No Abstract] [Full Text] [Related]
10. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
11. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
[TBL] [Abstract][Full Text] [Related]
12. NKT-cell subsets: promoters and protectors in inflammatory liver disease.
Kumar V
J Hepatol; 2013 Sep; 59(3):618-20. PubMed ID: 23669283
[TBL] [Abstract][Full Text] [Related]
13. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
14. NKT cells are important mediators of hepatic ischemia-reperfusion injury.
Richards JA; Wigmore SJ; Anderton SM; Howie SEM
Transpl Immunol; 2017 Dec; 45():15-21. PubMed ID: 28797737
[TBL] [Abstract][Full Text] [Related]
15. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
[TBL] [Abstract][Full Text] [Related]
16. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
18. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
Front Immunol; 2020; 11():610010. PubMed ID: 33312179
[TBL] [Abstract][Full Text] [Related]
19. RORγt(+) IL-22-producing NKp46(+) cells protect from hepatic ischemia reperfusion injury in mice.
Eggenhofer E; Sabet-Rashedi M; Lantow M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A
J Hepatol; 2016 Jan; 64(1):128-34. PubMed ID: 26341825
[TBL] [Abstract][Full Text] [Related]
20. Sulfatide-activated type II NKT cells suppress immunogenic maturation of lung dendritic cells in murine models of asthma.
Pan H; Zhang G; Nie H; Li S; He S; Yang J
Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L578-L590. PubMed ID: 31432714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
